Meeder Asset Management Inc Medpace Holdings, Inc. Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $9,143 - $11,496	-63 Reduced 10.26%	551 $87,000
Q2 2022 Aug 08, 2022	SELL	$130.2 - $168.03 $16,405 - $21,171	-126 Reduced 17.03%	614 $92,000
Q1 2022 May 10, 2022	BUY	$138.87 - $214.31 $102,763 - $158,589	740 New	740 $121,000
Q4 2021 Feb 11, 2022	SELL	$182.74 - $227.9 $125,542 - $156,567	-687 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$170.18 - $198.21 $7,828 - $9,117	-46 Reduced 6.28%	687 $130,000
Q2 2021 Aug 09, 2021	BUY	$158.62 - $194.3 $951 - $1,165	6 Added 0.83%	733 $129,000
Q1 2021 Apr 28, 2021	BUY	$132.02 - $168.26 $94,394 - $120,305	715 Added 5958.33%	727 $119,000
Q4 2020 Feb 09, 2021	BUY	$109.38 - $149.19 $546 - $745	5 Added 71.43%	12 $2,000
Q3 2020 Nov 02, 2020	BUY	$92.95 - $130.61 $92 - $130	1 Added 16.67%	7 $1,000
Q2 2020 Aug 11, 2020	BUY	$68.08 - $95.68 $408 - $574	6 New	6 $1,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.